Company Filing History:
4 out of 153 
2 out of 2 
2 out of 23 Years Active: 2018-2023
Title: Feihai Xu: Innovator in Detection Technologies
Introduction
Feihai Xu is a prominent inventor based in Xiamen, China. He has made significant contributions to the field of detection technologies, particularly in the quantitative detection of HBsAg and nucleic acid amplification.
Latest Patents
Feihai Xu holds four patents, showcasing his innovative approach to medical diagnostics. His latest patents include a kit and method for quantitative detection of HBsAg. This kit is designed for the quantitative detection of HBsAg and includes a first antibody that specifically binds to HBsAg, along with a reagent composition that contains tris(2-carboxyethyl)phosphine hydrochloride (TCEP) and urea. Another notable patent is a reaction tube for nucleic acid amplification, which is capable of controlling a liquid circulation path. This invention includes a reaction apparatus for nucleic acid amplification and a method for amplifying nucleic acid using the reaction tube.
Career Highlights
Feihai Xu has worked with esteemed institutions such as Xiamen University and Xiamen Innodx Biotech Co., Ltd. His work in these organizations has allowed him to develop and refine his innovative technologies.
Collaborations
Feihai Xu has collaborated with notable colleagues, including Shengxiang Ge and Jun Zhang. These partnerships have contributed to the advancement of his research and inventions.
Conclusion
Feihai Xu is a distinguished inventor whose work in detection technologies has the potential to impact medical diagnostics significantly. His innovative patents and collaborations highlight his commitment to advancing the field.